Emergent BioSolutions EBS
NYSE EBS
$6.76 +0.21 (+3.21%)
At close: Sep 22, 2026 · 4:00 PM EDT

Emergent BioSolutions (EBS) Inventory (2010 - 2026)

Emergent BioSolutions (EBS) posted Inventory of $303.6 million for Q2 2026, down 7.33% on a QoQ basis from $327.6 million in Q1 2026, and down 10.34% year-over-year from $338.6 million in Q2 2025.

Analysis

Emergent BioSolutions (EBS) Inventory (2010 - 2026) Analysis & Trends

Emergent BioSolutions has reported Inventory for 17 years, with the latest figure at $303.6 million in Q2 2026.

  • On a quarterly basis, Inventory fell 10.34% year-over-year to $303.6 million in Q2 2026; TTM through Jun 2026 was $303.6 million, a 10.34% decrease from a year earlier, with the FY2025 full-year figure at $343.4 million, up 10.17% from the prior year.
  • Inventory was $303.6 million for Q2 2026 at Emergent BioSolutions, down from $327.6 million in the prior quarter.
  • The five-year high for Inventory was $528.2 million in Q3 2022, with the low at $303.6 million in Q2 2026.
  • Average Inventory over 5 years is $354.4 million, with a median of $341.0 million recorded in 2025.
  • The sharpest annual moves came in 2022 and 2023: Inventory surged 44.87% in 2022, then sank 32.96% in 2023.
  • Over 5 years, Inventory stood at $350.7 million in 2022, then declined by 6.22% to $328.9 million in 2023, then slipped by 5.23% to $311.7 million in 2024, then climbed by 10.17% to $343.4 million in 2025, then slipped by 11.59% to $303.6 million in 2026.
  • The last three Inventory figures came in at $303.6 million (Q2 2026), $327.6 million (Q1 2026), and $343.4 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Inventory (Qtr)
1 Johnson & Johnson 649.47 Bn 628.71 Bn 17.26 Bn 15.14 Bn
2 AbbVie 467.46 Bn 460.93 Bn 12.70 Bn 5.13 Bn
3 Merck 369.31 Bn 362.22 Bn 12.21 Bn 6.21 Bn
4 Novartis Ag 269.03 Bn 261.74 Bn 11.24 Bn 6.22 Bn
5 Pfizer 158.11 Bn 146.71 Bn 10.94 Bn 9.95 Bn
6 Bristol Myers Squibb 127.96 Bn 116.89 Bn 9.25 Bn 2.74 Bn
7 Sanofi 51.83 Bn 44.86 Bn 10.79 Bn 12.93 Bn
8 BeOne Medicines 41.33 Bn 36.23 Bn 1.53 Bn 732.60 Mn
9 Revolution Medicines 41.30 Bn 41.30 Bn - -
10 Emergent BioSolutions 335.50 Mn 194.60 Mn 137.20 Mn 303.60 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 303.60 Mn
Mar 31, 2026 327.60 Mn
Dec 31, 2025 343.40 Mn
Sep 30, 2025 356.30 Mn
Jun 30, 2025 338.60 Mn
Mar 31, 2025 314.00 Mn
Dec 31, 2024 311.70 Mn
Sep 30, 2024 322.70 Mn
Jun 30, 2024 317.50 Mn
Mar 31, 2024 333.40 Mn
Dec 31, 2023 328.90 Mn
Sep 30, 2023 354.10 Mn
Jun 30, 2023 354.30 Mn
Mar 31, 2023 367.90 Mn
Dec 31, 2022 350.70 Mn
Sep 30, 2022 528.20 Mn
Jun 30, 2022 425.50 Mn
Mar 31, 2022 400.70 Mn
Dec 31, 2021 344.50 Mn
Sep 30, 2021 364.60 Mn
API Access

Emergent BioSolutions Inventory API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=inventory&ticker=EBS&period=max&api_key=YOUR_API_KEY